TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods. 

TCT 2024 | Utilización de balones cubiertos de fármacos para el tratamiento de la rama lateral en técnica de stent provisional

Based on the CHOICE-CLOSURE and MASH studies, double ProGlide use was associated with fewer access complications than the Manta device. Consequently, the former became the most accepted therapeutic option.

The ACCESS-TAVI study included patients with severe aortic stenosis scheduled for transfemoral TAVI, randomly assigned (1:1) to suture-and-plug closure (ProGlide and Angio-Seal) or suture-only closure (double ProGlide).

The primary objective was assessing a composite of major or minor vascular access-related complications (VARC-3 criteria) during hospitalization. Ultrasound-guided puncture was recommended, while secondary access was used at the operator’s discretion.

A total of 454 patients were included. Their average age was 80 years; 51.7% of subjects were women, and 11.3% had peripheral arterial disease. Among patients, 49.6% had no calcification, 21.9% had mild calcification, and 97% showed mild or no tortuosity. Ultrasound-assisted puncture was used in 57.8% of cases, and the right transfemoral access was the preferred choice (88.7%). A secondary transradial access was used in 40.9% of cases.

Read also: TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions.

In the analysis of the primary endpoint, vascular complications, the suture/plug group had 27% events vs 54% in the suture-only group, with a relative risk [RR] of 0.55 (95% confidence interval [CI]: 0.44-0.68; P ≤0.001). Reduced events were mainly due to fewer minor vascular complications and bleeding grade ≥ 2.

The authors concluded that the use of suture-and-plug closure reduces vascular complications compared with suture-only closure and is associated with shorter time to hemostasis.

Presented by Tobias A. Rheude in the Late-Breaking Trials Sessions, TCT 2024, October 27-29, Washington, USA.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Omar Tupayachi
Dr. Omar Tupayachi
Member of the Editorial Board of solaci.org

More articles by this author

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...

Cardiac Remodeling After Percutaneous ASD Closure: Should It Be Immediate or Progressive?

Atrial septal defect (ASD) is a common congenital heart disease that generates a left-to-right shunt, leading to right-side chamber overload and a risk of...

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...